Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Elle Sera is a UK-based female health company specializing in hormone-balancing nutraceuticals designed to support women through various life stages, including perimenopause and menopause. The company's flagship product is a potent, multi-ingredient supplement formulated with adaptogens and botanical extracts like Maca, Siberian Ginseng, and Tribulus Terrestris to regulate endocrine function. By focusing on the "Golden Pill" approach, Elle Sera aims to simplify female wellness by addressing symptoms such as fatigue, low libido, and mood swings through a single daily dose. The business operates primarily via a direct-to-consumer subscription model, positioning itself as a premium wellness brand in the rapidly growing "menopause tech" and longevity sectors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Elle Sera.